| Financial Year |
March 31 2023 |
| Monetary Funds |
4,352,850,543.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
228,325,658.51 |
| Accounts Receivable |
4,300,130,845.34 |
| Advances to Suppliers |
1,359,309,691.46 |
| Other Receivables |
741,542,065.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
187,376.32 |
| Dividend Receivable |
4,992,116.13 |
| Inventories |
6,039,168,763.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
46,632,199.70 |
| Other Current Assets |
649,727,073.33 |
| Total Current Assets |
18,656,064,007.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,195,722,854.11 |
| Investment Properties |
-- |
| Fixed Assetes |
8,188,521,621.46 |
| Under-construction Projects |
6,075,890,845.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,738,488,132.65 |
| R&D expenses |
-- |
| Goodwill |
1,007,279,852.19 |
| Long-Term Deferred and Prepaid Expenses |
153,914,999.03 |
| Deferred Income Tax Assets |
147,098,226.42 |
| Other Non-Current Assets |
839,446,947.61 |
| Sub-Total of Non-Current Assets |
28,228,279,532.46 |
| Total Assets |
46,884,343,539.90 |
| Short-Term Loans |
4,971,448,336.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,875,607,609.57 |
| Accounts Payable |
2,786,913,627.41 |
| Accounts Received In Advance |
949,682.02 |
| Employee Compensation Payable |
45,510,799.65 |
| Taxes Payable |
364,426,730.91 |
| Interest Payable |
-- |
| Dividend Payable |
701,360.00 |
| Other payables |
909,436,729.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,139,514,966.28 |
| Other Current Liabilities |
117,870,770.43 |
| Sub-Total of Current Liabilities |
12,302,413,460.35 |
| Long-term Loans |
6,299,810,072.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,701,156,058.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
54,941,349.57 |
| Deferred Income Tax Liabilities |
419,742,288.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,045,848,137.91 |
| Total Liabilities |
22,348,261,598.26 |
| Paid-In Capital(Or Share Stock) |
2,263,973,358.00 |
| Capital Surplus |
9,142,182,401.39 |
| Surplus Reserve |
292,801,918.55 |
| LESS:Treasury Stock |
745,427,227.00 |
| Undistributed Profits |
12,601,246,677.93 |
| Minority Stockholder's Interest |
972,677,438.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,563,404,503.44 |
| Owner's Equity（Stockholder's Equity） |
24,536,081,941.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,884,343,539.90 |
